R

Revolution Medicines

Clinical-stage oncology company developing RAS inhibitors

Market Access Director

Biology & BiotechConfirmed live in the last 24 hours
Full-timeRemote in PolandNo salary listed

About the Job

Requirements

  • A minimum of 10 years’ experience in market access, pricing, reimbursement, or health economics in Poland.
  • Proven value and benefit assessment experience, with a deep understanding of Poland payer decision-making.
  • Demonstrated experience supporting oncology product pre-launch, launch, and post-launch in Poland.
  • Demonstrated success negotiating pricing and reimbursement conditions with public administrations and health authorities.
  • Strong understanding of local healthcare systems, customer dynamics, and reimbursement environments.
  • Experience in a biotech company and/or in a build-out.

Responsibilities

  • Develop and implement strategies to support access and pricing decisions for the company portfolio and launches within the Poland healthcare system.
  • Lead preparation and submission of value dossiers and benefit assessments, and pricing negotiations with statutory health insurance decision makers.
  • Partner with regional and local Medical Affairs and Marketing teams to translate clinical and economic evidence into value communications tailored for Poland payers.
  • Build and maintain relationships with payers, HTA authorities, and policy influencers, and represent the company at local trade associations on market access subjects.
  • Work with Midsized Markets and Regional Market Access teams to align local access strategy with broader European and corporate objectives, including aligning European regulatory strategy and execution with local value dossier submission and pricing negotiation strategy.
  • Provide early market access input to regional and European clinical development and medical teams.
  • Lead negotiations with all levels of national payers.
  • Develop innovative pricing and value-based contracting models to accelerate reimbursement approvals.
  • Monitor health policy developments, HTA processes, and local reimbursement environments to inform strategy.
  • Represent Market Access in Poland Leadership Team meetings and contribute to overall business strategy.
  • Drive access and value-related projects, including landscape assessments, payer market research, payer advisory boards, and guidance on local strategies.
  • Develop an outreach and engagement plan for key payers and create and maintain a strong network.
  • Plan early access for new products and indications and drive launch readiness for multiple oncology assets.
  • Influence European and Midsized Markets access strategy based on local payer insights from a leadership position.
  • Travel nationally and internationally.

Desired Qualifications

  • Advanced degree in Life Sciences, Pharmacy, Health Economics, or Public Health.
  • Strong stakeholder management and ability to collaborate with internal and external partners.
  • High capacity for social competence in teamwork, coaching, and situational leadership.

About the Company

Revolution Medicines

Clinical-stage oncology company developing RAS inhibitors

Revolution Medicines develops precision oncology drugs focused on cancers driven by RAS mutations. Its RAS(ON) inhibitors are small molecules that bind the active form of RAS to block cancer signaling, with candidates like Daraxonrasib (RMC-6236), Elironrasib (RMC-6291), and Zoldonrasib (RMC-9805) advancing in global Phase 3 trials. The company funds its research through collaborations, royalties, and upfront funding, and has not yet marketed a product. Its goal is to bring effective RAS-targeted therapies to patients and advance multiple candidates through late-stage trials toward approval, supported by strong cash reserves.

Company size
1,001-5,000
Company stage
IPO
Headquarters
Redwood City, CA
Founded
2014

Recently Posted Jobs

Explore more opportunities at Revolution Medicines

See more jobs